| Glycerol, phosphoric acid |
Bronchoalveolar lavage fluid |
Discriminate lung cancer patients and healthy controls |
[5] |
| Hydroxylamine, threonine |
Serum |
Progression of lung cancer |
[6] |
| Monopalmitin, benzyl alcohol |
Expiration concentrate |
Discriminate lung cancer patients and healthy controls |
[7] |
| Phosphatidyl ethanolamine |
Serum |
Discriminate malignant and benign pulmonary nodules |
[8] |
| Putrescine, cysteamine |
Sputum |
Discriminate lung cancer patients and healthy controls |
[9] |
| Glutamic acid, choline, threonine |
Serum |
Discriminate non-small cell lung cancer patients and healthy controls |
[10] |
| Threonine, acetic acid, acetone |
Expiration concentrate |
Differentiate lung cancer patients and healthy controls |
[11] |
| Lactic acid, inositol, valine |
Tissue |
Discriminate malignant and benign pulmonary tissues |
[12] |
| Choline, carnitine |
Tissue |
Discriminate lung cancer tissues and normal tissues |
[13] |
| Diethyl spermine |
Serum |
Discriminate non-small cell lung cancer patients and healthy controls |
[14] |
| Glutamic acid, aspartic acid, xylose |
Serum and plasma |
Discriminate lung adenocarcinoma patients and healthy controls |
[15] |
| Phosphorylcholine, sphingosine |
Serum |
Discriminate lung cancer patients and healthy controls |
[16] |
| Glycerol, lactic acid, tryptophan |
Plasma |
Discriminate non-small cell lung cancer patients and normal persons |
[17] |
| Benzoic acid, lactic acid, glucose |
Plasma |
Discriminate lung cancer patients, smokers and non-smokers |
[18] |
| Glucose, cysteine, glucosamine |
Tissue |
Discriminate malignant and benign pulmonary tissues |
[19] |
| Bilirubin |
Serum |
Predict the lung cancer risk in smokers |
[20] |
| Octanedioic acid, tetrahexose |
Sweat |
Discriminate lung cancer patients and normal persons |
[21] |
| Hydroxybutyrate, alanine |
Cerebrospinal fluid |
Distinguish lung cancer leptomeningeal metastases |
[22] |
| Citric acid, choline, lysine |
Serum |
Discriminate non-small cell lung cancer and chronic obstructive pulmonary disease |
[23] |
| Choline, linoleic acid |
Serum |
Discriminate lung cancer patients and normal persons |
[24] |
| Carnitine, acetylcarnitine |
Urine |
Discriminate non-small cell lung cancer patients and normal persons |
[25] |
| Creatine ribonic acid, acetylneuraminic acid |
Urine |
Discriminate non-small cell lung cancer patients and normal controls |
[26] |
| Alanine, threonine, linoleic acid |
Plasma |
Discriminate lung adenocarcinoma patients and normal persons |
[27] |
| Citric acid, choline, leucine |
Serum |
Discriminate lung cancer and chronic respiratory disease |
[23] |
| Linoleic acid, hydroxy isobutyric acid |
Serum |
Discriminate lung cancer patients and normal persons |
[28] |
| Glutamic acid, erythritol, palmitic acid |
Plasma |
Discriminate small cell lung cancer patients and healthy controls |
[29] |
| Alanine, valine, isoleucine |
Plasma |
Discriminate non-small cell lung cancer patients and normal persons |
[30] |
| Hippuric acid, hydroxy isovaleric acid, creatinine |
Urine |
Discriminate lung cancer patients and healthy controls |
[31] |
| Tryptophan, hippuric acid, threonine |
Urine |
Discriminate lung cancer patients and normal persons |
[32] |
| Taurine, hippuric acid, carnitine |
Urine |
Discriminate lung cancer patients and normal persons |
[33] |
| Carnitine, propionylcarnitine, tyrosine, methionine, malic acid, histidine, 5-oxo-proline |
Serum |
Discriminate non-small cell lung cancer patients and normal persons |
[34] |
| Glucose, tyrosine, glycerol, valine |
Serum |
Discriminate lung cancer patients and non-cancer patients |
[35] |
| Benzaldehyde, urea, isoleucine, glycolic, phenylalanine |
Serum |
Discriminate early stages of lung cancer patients and normal persons |
[36] |